Opportunity ID: 354719

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-DK-25-012
Funding Opportunity Title: Single Source for the Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Food and Nutrition
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.847 — Diabetes, Digestive, and Kidney Diseases Extramural Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 05, 2024
Last Updated Date: Jun 05, 2024
Original Closing Date for Applications: Oct 24, 2024
Current Closing Date for Applications: Oct 24, 2024
Archive Date: Nov 29, 2024
Estimated Total Program Funding:
Award Ceiling: $5,500,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following:
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.

Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

See full Notice of Funding Opportunity for additional details on eligibility.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Notice of Funding Opportunity (NOFO) is a non-competitive funding opportunity intended to fund a single award. The NIDDK is announcing its intent to issue a single source cooperative agreement to the University of Pennsylvania to continue the mission of the existing Human Pancreas Analysis Program for Type 1 Diabetes (HPAP-T1D). This NOFO will support one team of investigators with combined expertise in human pancreas physiology and pathophysiology; immunology and autoimmunity; collection, processing and multimodal analysis of human pancreatic tissues and immune compartments; and biological database building, curation and management, that will be tasked to: 1) identify, collect and intensively characterize primary pancreatic tissues and immune cells from patients with type 1 diabetes (T1D) or at risk of developing the disease, as well as age-matched controls; and 2) analyze, organize and share the data resulting from the study of these tissues through the existing PANC DB open-access resource database. HPAP-T1D is a component of the Human Islet Research Network or HIRN. HIRN was created in 2014 to support innovative and collaborative translational research to understand how human beta cells are lost in T1D, and to find innovative strategies to protect and replace functional human beta cell mass.
Link to Additional Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-012.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH Grants Information
grantsinfo@nih.gov
Email:grantsinfo@nih.gov

Version History

Version Modification Description Updated Date

Folder 354719 Full Announcement-RFA-DK-25-012 -> RFA-DK-25-012-Full-Announcement.pdf

Packages

Agency Contact Information: NIH Grants Information
grantsinfo@nih.gov
Email: grantsinfo@nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-H Use for due dates on or after January 25, 2023 PKG00286860 Sep 24, 2024 Oct 24, 2024 View

Package 1

Mandatory forms

354719 RR_SF424_5_0-5.0.pdf

354719 PHS398_CoverPageSupplement_5_0-5.0.pdf

354719 RR_OtherProjectInfo_1_4-1.4.pdf

354719 PerformanceSite_4_0-4.0.pdf

354719 RR_KeyPersonExpanded_4_0-4.0.pdf

354719 PHS398_ResearchPlan_5_0-5.0.pdf

354719 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

354719 RR_Budget_3_0-3.0.pdf

354719 RR_SubawardBudget30_3_0-3.0.pdf

354719 PHS398_ModularBudget_1_2-1.2.pdf

354719 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-12T17:07:35-05:00

Share This Post, Choose Your Platform!

About the Author: